Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/21/2003WO2003068935A2 Methods of therapy and diagnosis
08/21/2003WO2003068924A2 Fusion proteins of humanized g250 specific antibodies and uses thereof
08/21/2003WO2003068920A2 Humanized gm-csf antibodies
08/21/2003WO2003068916A2 Methods and apparatus for whole cell panning
08/21/2003WO2003068915A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003WO2003068822A2 De-immunized (poly)peptide constructs
08/21/2003WO2003068821A2 Anti-cd20 antibodies and fusion proteins thereof and methods of use
08/21/2003WO2003068820A1 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068809A2 An herpes simplex virus complex
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068801A2 Antibody variants with faster antigen association rates
08/21/2003WO2003068800A2 Isolated peptides which bind to hla molecules and uses thereof
08/21/2003WO2003068799A2 Oligomeric molecules and uses thereof
08/21/2003WO2003068262A1 Alpha1beta1 antagonists for treatment of atherosclerosis
08/21/2003WO2003068261A2 Means and methods for altering the motility of the gastrointestinal tract
08/21/2003WO2003068260A1 Antibody-containing solution pharmaceuticals
08/21/2003WO2003068259A1 Antibody-containing solution pharmaceuticals
08/21/2003WO2003068258A1 7s immunoglobulin for treatment of choroidal neovascularisation_
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003054014A3 Apolipoprotein biopolymer markers predictive of alzheimers disease
08/21/2003WO2003045304A3 Mutable vaccines
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003040394A3 Production of recombinant proteins in vivo and use for generating antibodies
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003016471A3 Periostin-based diagnostic assays
08/21/2003WO2003014344A3 Expression of modified antibodies in avian cells
08/21/2003WO2003002609A3 Dual-specific ligand and its use
08/21/2003WO2002098459A3 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
08/21/2003WO2002074812A3 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002061090A3 Prokaryotically produced antibodies and uses thereof
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002050545A3 Compositions and methods involving staphylococcus aureus protein staau-r9
08/21/2003WO2002048405A3 Non-invasive method for detecting target rna
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044418A3 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002036615A3 Methods for producing and improving therapeutic potency of binding polypeptides
08/21/2003WO2002035240A3 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
08/21/2003WO2002032925A3 Protein scaffolds for antibody mimics and other binding proteins
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002012284A3 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2002004009A3 Method for treating cancer using an interleukin- 4 antagonist
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001085792A3 Mu-1, member of the cytokine receptor family
08/21/2003US20030158402 Stimulant immunology response; prevent infections
08/21/2003US20030158400 Antiinflammatory agents; autoimmune disease; rheumatic diseases; genetic engineered cells
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158398 Central nervous system disorders; psychological disorders
08/21/2003US20030158396 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
08/21/2003US20030158391 Anitbodies and method for producing same, the use thereof and immunisation cocktails, immunoassays-sets and peptides
08/21/2003US20030158389 Immunoglobulins; genetic engineering
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158379 A DNA molecules encoding the proteins, used in the treatment of bone, connective tissue, tendon, ligament, wound healing and defects to tissues, animal growth factors, cell differentiation of embryonic and stem cells
08/21/2003US20030158136 Materials and methods relating to immune responses to fusion proteins
08/21/2003US20030158135 Derived from staphylococcal genes; use of the polynucleotides as oligonucleotide primers or probes for detecting Staphylococcal strains that are resistant to streptogramin A or streptogramin B and related compounds in biological sample
08/21/2003US20030158123 Purified material having size and growth inhibitory effects on cells and tissues
08/21/2003US20030158115 Prevents adhesion of specific crystals to the surface of kidney cells and is used in an assay system to rapidly measure relative amounts of crystal adhesion to cells
08/21/2003US20030158104 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158085 For diagnosis and therapy of pancreatic disorders, particularly type I diabetes
08/21/2003US20030157660 Non-M, non-O HIV-1 strains, fragments and uses
08/21/2003US20030157649 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003US20030157641 Polycistronic expression of antibodies
08/21/2003US20030157633 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
08/21/2003US20030157632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157631 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157630 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157629 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157628 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157626 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157624 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157623 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157621 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157620 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157619 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157617 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157616 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157614 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157613 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157612 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157611 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157610 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 ... 1494